Newly Diagnosed Breast Cancer Patients Choose Bilateral Mastectomy Over Breast-Conserving Surgery When Testing Positive for a BRCA1/2 Mutation

Stolier, Alan J.; Corsetti, Ralph L.
December 2005
American Surgeon;Dec2005, Vol. 71 Issue 12, p1031
Academic Journal
In women diagnosed with breast cancer and testing positive for a BRCA1/2 mutation, decisions as to whether to undergo prophylactic risk-reduction surgery may differ from those women who test positive in a presymptomatic phase. Eighty-four women were identified who had undergone genetic testing at the time of breast cancer diagnosis. The study group consisted of 46 of these women who had initially undergone breast-conserving surgery. Eight patients (17.4%) tested positive for a mutation. Seven of the eight underwent bilateral prophylactic mastectomy prior to receiving radiation therapy. The only patient not undergoing bilateral mastectomy was awaiting liver transplant. Women who are candidates for breast-conserving surgery and who test positive for a breast cancer gene mutation choose mastectomy over surveillance.


Related Articles

  • BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Robertson, L; Hanson, H; Seal, S; Warren-Perry, M; Hughes, D; Howell, I; Turnbull, C; Houlston, R; Shanley, S; Butler, S; Evans, D G; Ross, G; Eccles, D; Tutt, A; Rahman, N // British Journal of Cancer;3/13/2012, Vol. 106 Issue 6, p1234 

    Background:Triple-negative (TN) tumours are the predominant breast cancer subtype in BRCA1 mutation carriers. Recently, it was proposed that all individuals below 50 years of age with TN breast cancer should be offered BRCA testing. We have evaluated the BRCA1 mutation frequency and the...

  • Screening for Hereditary Breast Ovarian Syndrome. Kurian, Shiney // Journal of Gynecologic Oncology Nursing;Spring2006, Vol. 16 Issue 2, p35 

    Presents information on the medical screening for hereditary breast ovarian syndrome. Discussion on the high risk of women who tested positive for carrying the breast cancer gene BRCA mutations for developing breast and ovarian cancer; Need for women at risk for hereditary breast ovarian cancer...

  • Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Watson, M; Foster, C; Eeles, R; Eccles, D; Ashley, S; Davidson, R; Mackay, J; Morrison, P J; Hopwood, P; Evans, D G R; Psychosocial Study Collaborators // British Journal of Cancer;11/15/2004, Vol. 91 Issue 10, p1787 

    This multi-centre UK study assesses the impact of predictive testing for breast and ovarian cancer predisposition genes (BRCA1/2) in the clinical context. In the year following predictive testing, 261 adults (59 male) from nine UK genetics centres participated; 91 gene mutation carriers and 170...

  • Genetic Testing Can Aid in Predicting Cancer Risk.  // Women's Health Advisor;Feb2013, Vol. 17 Issue 2, p1 

    The article presents information on genetic testing that aid in determining several future disease risks including breast cancer, Alzheimer's and diabetes in which chromosomes, genes and proteins in the blood sample are analyzed for disease prediction. INSETS: WHAT YOU SHOULD KNOW;WHO SHOULD BE...

  • Genetic testing delivers ammo against cancer.  // Filipino Post;9/1/2011, p10 

    The article reports on the importance of considering the one's family and personal histories when thinking about the chances of having breast and ovarian cancer as well as the use of Hereditary Breast and Ovarian Cancer syndrome (HBOC) test for women with a family history of the said cancers.

  • Breast cancer genetic screening and clinical bioethics' gaze. Parker, Lisa S. // Journal of Medicine & Philosophy;Jun95, Vol. 20 Issue 3, p313 

    Illustrates a role that bioethics should play in developing and criticizing protocols for breast cancer genetic screening. How a critical bioethics may critically interrogate the normative and conceptual schemes within which ethical considerations about such screening protocols are framed;...

  • Ethnic, Racial and Cultural Identity and Perceived Benefits and Barriers Related to Genetic Testing for Breast Cancer among At-Risk Women of African Descent in New York City. Sussner, K.M.; Edwards, T.A.; Thompson, H.S.; Jandorf, L.; Kwate, N.O.; Forman, A.; Brown, K.; Kapil-Pair, N.; Bovbjerg, D.H.; Schwartz, M.D.; Valdimarsdottir, H.B. // Public Health Genomics;2011, Vol. 14 Issue 6, p356 

    Background: Due to disparities in the use of genetic services, there has been growing interest in examining beliefs and attitudes related to genetic testing for breast and/or ovarian cancer risk among women of African descent. However, to date, few studies have addressed critical cultural...

  • (DUKE=20 RESEARCH) Patents Disrupt Competition, Innovation in Gene = Testing=20.  // Aging News Alert;4/16/2010, p12 

    The article focuses on the exclusive licenses to patents of gene testing in the U.S. It capacitates in doing more to block competition in the gene testing market rather than spurring the development of the new technologies for gauging disease risk. It delineates the result of the case studies...

  • Living with Lethal Genes: Some Advice. Gwynne, S.C. // Time;10/12/1998, Vol. 152 Issue 15, p89 

    Describes the use of genetic tests at Duke University Medical Center, Durham, North Carolina. The case of Kristen, who underwent a genetic test that indicated she was likely to develop breast cancer again; The history of genetic mutation in her family; Impact of research on patients at Duke;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics